DNTH
Dianthus Therapeutics, Inc. · Healthcare
Fairmount Funds Management LLC bought $396K of Dianthus Therapeutics, Inc.
Director and 10% owner
Bought$396,000
$13.20Price
30,000Shares
+2%Stake
What DNTH did for a copier
- $1,000 copied at Fri, Sep 22 open, $12.76
- $940
- S&P 500, same days
- +0.5%
Measured over 30 trading days, to the Nov 3 close.
Fairmount Funds Management LLC's record
17 other buys with 3 months of prices since 2021: on average −7.5% against the S&P 500, and 6 of 17 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Sep 19. Filed Thu, Sep 21, 4:23 PM ET, after the close. Returns use the Sep 22 open and the Nov 3 close. Not investment advice.